🇺🇸 FDA
Pipeline program

Precision Cells

NBWYKY2016-06-005

Phase 2 mab active

Quick answer

Precision Cells for Precision Cell Immunotherapy is a Phase 2 program (mab) at Ningbo Cancer Hospital with 1 ClinicalTrials.gov record(s).

Program details

Company
Ningbo Cancer Hospital
Indication
Precision Cell Immunotherapy
Phase
Phase 2
Modality
mab
Status
active

Clinical trials